Examination of the Cevimeline Hydrochloride Hydrate Concomitant Hachiazule and Xylocaine Gargle Therapy

Hiroshi Mese, Akira Sasaki, Katsushi Furuno

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A gargling treatment by Hachiazele and Xylocaine is useful for a stomatitis treatment of the oral cancer patient with chemotherapy and/or radiotherapy. However, there is a little improvement of dry mouth. Aiming at improvement of dry mouth for the oral cancer patient with chemotherapy and/or radiotherapy, we reviewed the cevimeline hydrochloride hydrate concomitant Hachiazule and Xylocaine gargling therapeutic safety. Homeostasis for ten days of cevimeline hydrochloride hydrate was confirmed in all condition by an incompatibility examination. It was significant, and the group of cevimeline hydrochloride hydrate combination elevated salivation dosage in comparison with a non-concomitant group. In addition, the side effect did not accept both groups together. As for the cevimeline hydrochloride hydrate combination Haciazule and Xylocaine gargling treatment, it was thought that beneficial gargling was therapeutic for dry mouth of the oral cancer patient with chemotherapy and/or radiotherapy.

Original languageEnglish
Pages (from-to)56-57
Number of pages2
JournalJournal of Hard Tissue Biology
Volume14
Issue number2
DOIs
Publication statusPublished - 2005

Fingerprint

Mouth Neoplasms
Lidocaine
Hydrates
Chemotherapy
Radiotherapy
Drug Therapy
Salivation
Therapeutics
Stomatitis
Mouth
Homeostasis
cevimeline
Safety

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biochemistry
  • Biomaterials
  • Orthopedics and Sports Medicine
  • Dentistry(all)
  • Cell Biology

Cite this

Examination of the Cevimeline Hydrochloride Hydrate Concomitant Hachiazule and Xylocaine Gargle Therapy. / Mese, Hiroshi; Sasaki, Akira; Furuno, Katsushi.

In: Journal of Hard Tissue Biology, Vol. 14, No. 2, 2005, p. 56-57.

Research output: Contribution to journalArticle

@article{a256c46f5fb54a6baa16f30d7a568c97,
title = "Examination of the Cevimeline Hydrochloride Hydrate Concomitant Hachiazule and Xylocaine Gargle Therapy",
abstract = "A gargling treatment by Hachiazele and Xylocaine is useful for a stomatitis treatment of the oral cancer patient with chemotherapy and/or radiotherapy. However, there is a little improvement of dry mouth. Aiming at improvement of dry mouth for the oral cancer patient with chemotherapy and/or radiotherapy, we reviewed the cevimeline hydrochloride hydrate concomitant Hachiazule and Xylocaine gargling therapeutic safety. Homeostasis for ten days of cevimeline hydrochloride hydrate was confirmed in all condition by an incompatibility examination. It was significant, and the group of cevimeline hydrochloride hydrate combination elevated salivation dosage in comparison with a non-concomitant group. In addition, the side effect did not accept both groups together. As for the cevimeline hydrochloride hydrate combination Haciazule and Xylocaine gargling treatment, it was thought that beneficial gargling was therapeutic for dry mouth of the oral cancer patient with chemotherapy and/or radiotherapy.",
author = "Hiroshi Mese and Akira Sasaki and Katsushi Furuno",
year = "2005",
doi = "10.2485/jhtb.14.56",
language = "English",
volume = "14",
pages = "56--57",
journal = "Journal of Hard Tissue Biology",
issn = "1341-7649",
publisher = "Society of Hard Tissue Regenerative Biology",
number = "2",

}

TY - JOUR

T1 - Examination of the Cevimeline Hydrochloride Hydrate Concomitant Hachiazule and Xylocaine Gargle Therapy

AU - Mese, Hiroshi

AU - Sasaki, Akira

AU - Furuno, Katsushi

PY - 2005

Y1 - 2005

N2 - A gargling treatment by Hachiazele and Xylocaine is useful for a stomatitis treatment of the oral cancer patient with chemotherapy and/or radiotherapy. However, there is a little improvement of dry mouth. Aiming at improvement of dry mouth for the oral cancer patient with chemotherapy and/or radiotherapy, we reviewed the cevimeline hydrochloride hydrate concomitant Hachiazule and Xylocaine gargling therapeutic safety. Homeostasis for ten days of cevimeline hydrochloride hydrate was confirmed in all condition by an incompatibility examination. It was significant, and the group of cevimeline hydrochloride hydrate combination elevated salivation dosage in comparison with a non-concomitant group. In addition, the side effect did not accept both groups together. As for the cevimeline hydrochloride hydrate combination Haciazule and Xylocaine gargling treatment, it was thought that beneficial gargling was therapeutic for dry mouth of the oral cancer patient with chemotherapy and/or radiotherapy.

AB - A gargling treatment by Hachiazele and Xylocaine is useful for a stomatitis treatment of the oral cancer patient with chemotherapy and/or radiotherapy. However, there is a little improvement of dry mouth. Aiming at improvement of dry mouth for the oral cancer patient with chemotherapy and/or radiotherapy, we reviewed the cevimeline hydrochloride hydrate concomitant Hachiazule and Xylocaine gargling therapeutic safety. Homeostasis for ten days of cevimeline hydrochloride hydrate was confirmed in all condition by an incompatibility examination. It was significant, and the group of cevimeline hydrochloride hydrate combination elevated salivation dosage in comparison with a non-concomitant group. In addition, the side effect did not accept both groups together. As for the cevimeline hydrochloride hydrate combination Haciazule and Xylocaine gargling treatment, it was thought that beneficial gargling was therapeutic for dry mouth of the oral cancer patient with chemotherapy and/or radiotherapy.

UR - http://www.scopus.com/inward/record.url?scp=75749098370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749098370&partnerID=8YFLogxK

U2 - 10.2485/jhtb.14.56

DO - 10.2485/jhtb.14.56

M3 - Article

AN - SCOPUS:75749098370

VL - 14

SP - 56

EP - 57

JO - Journal of Hard Tissue Biology

JF - Journal of Hard Tissue Biology

SN - 1341-7649

IS - 2

ER -